ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University College London at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University College London takes part in 12 sessions at ESMO 2026 in Madrid. Its work links cancer biology and molecular profiling with treatment decisions across tumour types. It examines whether a gene-expression profile can guide treatment intensification for very high-risk prostate cancer.

OrganizationESMO 2026 Attendance
University College London
London, United Kingdom
University & institute
Public research university in London, England, with a medical school and a cancer institute.
Poster
Fri Oct 23
13:00–15:00
Chair
Fri Oct 23
13:30–15:00
Key biological concepts and their clinical implication
with National Autonomous University of Mexico
Biomarkers & precision oncology
Talk
Fri Oct 23
13:50–14:10
Chromosomal instability and structural alterations underpinning tumour development
Key biological concepts and their clinical implication
Biomarkers & precision oncology
Talk
Fri Oct 23
14:10–14:30
Cancer cell plasticity and cancer evolution
Key biological concepts and their clinical implication
Biomarkers & precision oncology
Abstract
Sat Oct 24
11:10–11:20
Chair
Sat Oct 24
14:45–16:00
Management of locally advanced HCC
with Hospital Universitario Fundación Jiménez Díaz
Gastrointestinal cancers
Talk
Sat Oct 24
14:50–15:05
View of the medical oncologist: Integration of systemic therapies with locoregional therapy
Management of locally advanced HCC
Gastrointestinal cancers
Talk
Sun Oct 25
11:15–11:30
Advanced/metastatic prostate cancer: Discussion
ESMO Clinical Practice Guidelines 2
Breast cancerGenitourinary cancers
Poster
Sun Oct 25
12:00–12:45
Survival of advanced lung cancer when screen-detected versus diagnosed clinically, in a screened cohort
Sunday Poster Display session 5
Lung & thoracic cancers
Chair
Sun Oct 25
14:45–16:15
Proffered paper 1: Basic science and translational research
with Institute of Oncology Research (IOR)
Abstract
Sun Oct 25
14:50–14:55
Abstract
Sun Oct 25
15:05–15:15
4237O - Radiological tracking of metastatic growth and its molecular correlates in lung cancer
Proffered paper 1: Basic science and translational research
Abstract
Sun Oct 25
15:57–16:07
Invited Discussant 4238O and 4239O
Proffered paper 1: Basic science and translational research
Poster
Mon Oct 26
12:00–12:45
10 year survival after elective neck dissection for early stage oral cancer: SEND multicentre randomised trial and real-world study
Monday Poster Display session 2
Sarcoma, CNS, head & neck and rare cancers
Poster
Mon Oct 26
12:00–12:45
RODEO: pReOperative dostarlimab and novel therapies in endometrial cancer
Monday Poster Display session 1
Gynaecological cancers
Keynote
Mon Oct 26
12:15–12:20
Introduction
Keynote lecture 4
Chair
Mon Oct 26
12:15–12:45
Abstract
Mon Oct 26
15:05–15:17
Invited Discussant 4241O and 4243O
Proffered paper 2: Basic science and translation research
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University College London

Tell us what you sell and we’ll find the people at University College London most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction